Conference Coverage
Conference Coverage
Multiple DMTs linked to alopecia, especially in women
Several medications weren’t previously implicated in hair loss, researchers report.
Conference Coverage
Certain DMTs in MS linked to more psoriasis
Few cases overall were reported, but researchers still urge caution in drug selection.
Conference Coverage
Which agent is best for neuromyelitis optica?
Researchers conducted an indirect treatment comparison on the efficacy of the three FDA-approved treatment options for adults with AQP4+ NMOSD.
Conference Coverage
Two diets linked to improved cognition, fatigue in MS
These results are among the first to show diet-related favorable reductions in cognitive dysfunction.
Conference Coverage
MS and COVID: Docs switched DMTs but maybe didn’t need to
Switching was rampant early on, a survey finds, but a new study suggests specific drugs don’t boost risk.
Conference Coverage
Good data is lacking on best first-line MS drug strategies
But new studies will offer guidance on escalation versus early-intensive approaches.
Conference Coverage
Pain in MS: Focus on flexibility, multiple strategies, and nondrug treatments
Specialist urges colleagues to think outside the pharmacy and understand syndromes.
Conference Coverage
Steroid-induced psychosis in MS? Quetiapine may help
Popular antipsychotic helped Canadian patients recover from psychiatric distress.
Conference Coverage
Antiepileptic medications linked to increased priapism risk
If clinicians encounter such cases of priapism, they should be “reported to the regulatory authorities,” said lead researcher Dr. Ana Pejcic.
Conference Coverage
Stem cell transplant benefits in secondary progressive MS
The procedure was associated with a slowing of disability progression and a higher likelihood of disability improvement.
Conference Coverage
Updated MS guidelines advocate earlier, more aggressive treatment
The updated guidelines address the efficacy of disease-modifying therapies, early treatment decisions, disease/treatment response monitoring and...